Skip to main content
Tech.euFundingExplorerBeta

INKEF Capital

Investor profile

Investment firmVenture capital

Also recorded as: Inkef Capital

Deals
49
distinct rounds
Companies
41
backed
Active span
2014–2026
13 yrs
Total round €
€1.2B
sum of rounds joined

Deals by year

distinct rounds / year

Top sectors

by deals

Stages

by deals

Countries

by deals

Co-investment network

shared rounds
INKEF CapitalLSPBioMedPartnersCoatueCrane Venture PartnersFundPlusGilde HealthcareGIMVGlobal PayTech VenturesHadean VenturesNovo HoldingsPartech VenturesAndera PartnersCurie CapitalEIC FundFirst VentureHealth InnovationsInvest-NLJeito Capital

Hover a node for shared-deal counts; click a co-investor to open its profile.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Quantum MotionUK2€184M
iOncturaSwitzerland2€95M
PrecirixBelgium1€80M
Urban Sports ClubGermany1€80M
Ambagon TherapeuticsNetherlands1€75M
ViCentraNetherlands1€65M
SilverflowNetherlands3€65M
Cardior PharmaceuticalsGermany1€64M
Salvia BioElectronicsNetherlands1€53M
ChannelEngineNetherlands2€50M
TargED BiopharmaceuticalsNetherlands1€39M
TargED BiopharmaceuticalNetherlands1€39M
CastorNetherlands1€38M
HappeoFinland2€36M
NMD PharmaDenmark1€35M
Scenic BiotechNetherlands1€28M
OnwardNetherlands1€27M
G-TherapeuticsNetherlands1€26M
BloomonNetherlands2€24M
Calypso BiotechNetherlands1€20M
lengooGermany1€17M
NightBalanceNetherlands1€13M
Draupnir BioDenmark1€12M
AidenceNetherlands1€10M
InteRNA TechnologiesNetherlands1€9.5M
Anavo TherapeuticsNetherlands1€8.5M
CrowdynewsNetherlands2€6.2M
SentinelsNetherlands1€5.7M
EclecticIQNetherlands1€5.5M
Castor EDCNetherlands1€5.3M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Quantum MotionSeries C€136M2026-05
Urban Sports ClubOther€80M2021-07
iOncturaSeries B€80M2024-06
PrecirixSeries B€80M2022-03
Ambagon TherapeuticsSeries A€75M2022-01
ViCentraSeries C€65M2021-12
Cardior PharmaceuticalsSeries B€64M2021-08
Salvia BioElectronicsSeries B€53M2025-05
Quantum MotionSeries B€47M2023-02
ChannelEngineSeries B€45M2022-03
← Back to investors